V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210003622 | 210009154 | 1.58 | 88.8 | null | null | 2018-11-21 | PERTUZUMAB + TRASTUZUMAB | null | null | PERTUZUMAB + TRASTUZUMAB | 100628901 |
| 210003627 | 210009156 | 1.71 | 68.4 | Palliative (P) | 2018-08-24 | 2018-11-18 | Palbociclib | 02 | N | CAPECITABINE | 101068345 |
| 210003628 | 210009157 | null | null | Palliative (P) | 2018-08-02 | 2018-08-16 | GemCarbo Days 1+8 | 02 | N | ATEZOLIZUMAB + NAB-PACLITAXEL | 100983156 |
| 210003629 | 210009158 | 1.64 | 66 | null | 2017-12-01 | 2018-02-17 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101399238 |
| 210003632 | 210009159 | 1.65 | 75.4 | null | 2019-10-31 | 2019-11-07 | Capecitabine | 02 | null | CAPECITABINE | 100630244 |
| 210003633 | 210009160 | 1.69 | 78 | Palliative (P) | 2016-05-24 | 2016-10-27 | NAB PACLITAXEL | 02 | N | OLAPARIB | 100306543 |
| 210003635 | 210009162 | 1.58 | 55 | null | 2016-03-31 | 2016-04-07 | FEC | 02 | null | ROSCO TRIAL | 101110095 |
| 210003637 | 210009163 | 1.55 | 45.8 | null | 2018-06-14 | 2018-06-27 | null | N | null | CAPECITABINE | 100715250 |
| 210003638 | 210009164 | 1.56 | 0 | null | 2017-03-21 | 2017-04-12 | Capecitabine 35days + RT | null | null | CAPECITABINE | 100694326 |
| 210003641 | 210009166 | 1.69 | 65 | null | 2019-10-27 | 2019-11-05 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100075897 |
| 210003643 | 210009167 | 1.63 | 51.6 | Palliative (P) | 2018-10-26 | 2018-11-10 | Vinorelbine (oral) | 02 | N | VINORELBINE | 101860198 |
| 210003646 | 210009169 | 1.61 | 72.9 | null | 2016-06-16 | 2016-06-23 | null | 02 | null | EC | 100777280 |
| 210003648 | 210009171 | null | null | Adjuvant (A) | 2017-11-23 | 2017-12-07 | ROSCO Trial | 02 | N | CARBOPLATIN + DOCETAXEL | 100213352 |
| 210003650 | 210009173 | 1.75 | 65 | Palliative (P) | 2020-12-04 | 2020-12-04 | VINORELBINE | 02 | N | VINORELBINE | 101174760 |
| 210003653 | 210009175 | 0 | 86.6 | Adjuvant (A) | null | 2017-09-27 | Carboplatin + Paclitaxel (weekly) | 02 | N | FULVESTRANT + PALBOCICLIB | 101719302 |
| 210003659 | 210009179 | 1.63 | 88.8 | Adjuvant (A) | 2015-03-21 | 2019-04-02 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | Y | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100522340 |
| 210003663 | 210009183 | 0 | 91.5 | null | 2018-01-19 | 2018-01-22 | null | 02 | null | LETROZOLE + PALBOCICLIB | 100137596 |
| 210003668 | 210009186 | 1.66 | 89.7 | null | null | 2021-09-30 | Capecitabine | 02 | null | CAPECITABINE | 100079302 |
| 210003672 | 210009188 | 1.7 | 87.5 | null | 2019-01-23 | 2019-02-02 | null | 02 | null | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100798161 |
| 210003678 | 210009193 | 1.62 | 65.3 | null | null | 2014-06-19 | GEMCARBO | null | null | CARBOPLATIN + GEMCITABINE | 100035580 |
| 210003679 | 210009194 | null | null | null | 2017-07-30 | 2018-06-26 | TRASTUZUMAB EMTANSINE | null | null | EC | 101863233 |
| 210003684 | 210009197 | 1.61 | 80.3 | Adjuvant (A) | 2019-09-23 | 2019-12-30 | FEC 60 or 75 | N | N | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100358673 |
| 210003689 | 210009200 | 1.56 | 72.7 | null | 2019-04-14 | 2019-08-07 | null | 02 | null | EPIRUBICIN | 101857012 |
| 210003690 | 210009201 | 1.58 | 63.8 | null | null | 2017-12-31 | Trial Unspecified | null | null | TRIAL UNSPECIFIED | 100856400 |
| 210003691 | 210009202 | 1.65 | 47.5 | Palliative (P) | 2019-01-28 | 2019-02-07 | null | 01 | N | CARBOPLATIN | 100478792 |
| 210003693 | 210009204 | 1.61 | 73.75 | Adjuvant (A) | 2018-05-22 | 2018-06-13 | Capecitabine | 02 | N | CAPECITABINE | 100959064 |
| 210003698 | 210009206 | 1.65 | 88.4 | null | 2020-08-05 | 2020-08-22 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100105527 |
| 210003699 | 210009207 | null | null | null | 2018-05-04 | 2018-05-05 | GEMCARBO | 02 | null | CARBOPLATIN + GEMCITABINE | 101267281 |
| 210003700 | 210009208 | null | 60.8 | null | 2016-12-31 | 2017-01-23 | GEMCARBO | 02 | null | CARBOPLATIN + GEMCITABINE | 100539097 |
| 210003705 | 210009211 | 1.61 | 91 | Palliative (P) | 2018-08-31 | 2018-09-06 | VINORELBINE | 02 | N | VINORELBINE | 100776863 |
| 210003707 | 210009213 | 1.66 | 84.8 | null | 2017-03-15 | 2017-03-15 | Pertuzumab (Loading) | 02 | null | PERTUZUMAB | 101126331 |
| 210003709 | 210009215 | 1.75 | 123.3 | null | 2018-07-17 | 2018-08-09 | null | 02 | null | EPIRUBICIN | 101085234 |
| 210003711 | 210009216 | null | null | null | 2016-06-29 | 2016-07-11 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101335670 |
| 210003712 | 210009217 | 1.69 | null | null | 2018-08-01 | 2018-08-03 | Palbociclib | null | null | EPIRUBICIN | 101840371 |
| 210003714 | 210009219 | 0 | 58.6 | Adjuvant (A) | 2016-11-26 | 2020-03-20 | Letrozole + Palbociclib | 02 | N | CARBOPLATIN + DOCETAXEL | 101340915 |
| 210003715 | 210009220 | null | 84.3 | null | 2016-07-14 | 2018-02-07 | null | N | null | EC | 100242146 |
| 210003721 | 210009225 | 0 | 94.2 | Neo-adjuvant (N) | null | 2019-04-17 | null | null | N | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100577965 |
| 210003722 | 210009226 | 1.63 | 77.4 | null | 2016-08-24 | 2017-01-31 | Carboplatin + Docetaxel | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100420307 |
| 210003723 | 210009227 | 1.73 | 53.9 | Neo-adjuvant (N) | null | 2019-11-05 | Capecitabine | 02 | N | LETROZOLE + PALBOCICLIB | 100832036 |
| 210003724 | 210009228 | 1.71 | 87.35 | null | 2019-03-08 | 2019-05-04 | Capecitabine | null | null | CAPECITABINE | 100138044 |
| 210003725 | 210009229 | 1.54 | 67.9 | null | 2016-11-17 | 2016-12-10 | TCH (21 day Trastuzumab) Maint | null | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100388097 |
| 210003727 | 210009230 | 1.57 | 68.5 | Adjuvant (A) | 2016-10-08 | 2016-10-09 | null | null | N | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 101141121 |
| 210003729 | 210009232 | 1.68 | 63.6 | Palliative (P) | 2018-04-03 | 2018-04-25 | Pertuzumab (Loading) | 01 | N | PERTUZUMAB | 100347717 |
| 210003733 | 210009234 | 1.68 | 58.2 | null | null | 2019-07-16 | Pertuzumab (Maintenance) | 02 | null | PERTUZUMAB | 100652022 |
| 210003735 | 210009235 | null | 75.6 | Palliative (P) | 2019-03-23 | 2019-05-20 | DOCETAXEL + TRASTUZUMAB | 02 | N | PACLITAXEL + TRASTUZUMAB | 100843950 |
| 210003736 | 210009236 | 1.6 | 56 | null | 2018-08-31 | 2018-11-03 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101855705 |
| 210003738 | 210009237 | null | null | null | 2018-09-25 | 2018-10-05 | Pertuzumab (Loading) | 02 | null | PERTUZUMAB | 100565820 |
| 210003747 | 210009243 | 1.68 | 90 | null | 2020-05-24 | 2021-05-12 | Letrozole + Palbociclib | 02 | null | CARBOPLATIN + DOCETAXEL | 101834068 |
| 210003750 | 210009246 | null | null | Neo-adjuvant (N) | 2019-01-13 | 2019-01-27 | null | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101617762 |
| 210003754 | 210009250 | 1.68 | 56.7 | null | 2018-06-20 | 2018-09-06 | CARBOPLATIN + PACLITAXEL | 02 | null | LETROZOLE + PALBOCICLIB | 100575774 |